Azithromycin

Azithromycin ( Cas No.: 83905-01-5 ) is a macrolide derived from erythromycin. Azithromycin is a broad-spectrum antibiotic which is widely used to treat variety of bacterial infections by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. It results in prevention and multiplication of bacterial growth. Azithromycin shows action against both gram positive and gram-negative bacteria, as well as a pathogen such as Mycoplasma pneumoniae, Chlamydia trachomatis, and Legionella pneumophila.

Azithromycin exhibits extended half-life and tissue penetration which allows shorter treatment courses, enhancing patient compliance. Azithromycin is used to treat diseases such as respiratory tract infections, skin infections, ear infections, and sexually transmitted diseases.

Chemox Pharma is leading manufacturer of Azithromycin which supports all regulatory documents such as WHO-GMP, FDA and DCGI. Chemox Pharma also house a well-equipped R&D Centre, focused on process development, quality improvement, and cost optimization—empowering us to meet the evolving needs of the global pharmaceutical industry.